CMS — CMS Energy Corporation

The tape is cautious: the stock has fallen into the low end of its 52-week range and momentum is negative, but the sell-side backdrop is constructive (16 buys, 14 holds, 0 sells) and management reaffirmed 2026 EPS guidance. Those opposing forces leave sentiment balanced rather than bullish or bearish.

Revenue has trended up modestly, but the earnings path is choppy. TTM revenue through Q2 2026 is about $8.81B, up ~10% from the prior TTM, while TTM EPS is essentially flat (~$3.38 vs ~$3.39) because Q2 2026 was a weak quarter: GAAP EPS fell to $0.39 from $0.66 a year earlier (adjusted $0.37 vs $0.71 per the brief) on weather and storm-cost timing. Q1 2026 EPS grew ~12% YoY, which shows this is a seasonal blip, not a structural decline. The bigger structural story is the capex build: TTM capex is ~$4.06B, up from ~$3.50B a year ago, driving TTM FCF to -$1.91B.

Valuation is fair. The stock trades at 20.2x TTM EPS of $3.41, slightly above its 5-year average P/E of 19.1, but only ~17.7x the 2026 EPS guidance midpoint of $3.87. P/S of 2.43 is also essentially in line with the 5-year average of 2.41. For a regulated utility with a visible 6-8% EPS growth algorithm and a 3.2% yield, that is neither cheap nor expensive.

The price decline from the 80.36 high to 68.35 was mostly multiple compression (from ~23.5x TTM EPS to ~20.2x) because forward estimates were reaffirmed, not cut. The stock is not pricing in aggressive growth; it would need to return to just a 19x forward multiple to reach the mid-$70s. Upside depends on execution: clean Q3 results, the NorthStar asset sale, and no negative rate-case surprises.

As of 2026-08-27, RSI was 33.98, near oversold but not yet at a capitulation-level extreme. The stock was 2.7% below its 20-day SMA, 6.6% below its 50-day SMA, and 7.3% below its 200-day SMA, and it is testing the low end of the 52-week range at $67.90. The trend is down; a stabilization/reclaim of $70-71 would be the first sign of a base, while a close below $67.90 would signal further downside.

• Interest rates and Treasury yields: utility valuations remain inversely tied to the 10-year yield; sticky yields have pressured the group.
• Federal Reserve policy: a clearer easing path would likely support a re-rating of rate-sensitive regulated utilities.
• Michigan regulatory environment: constructive rate-case outcomes on pipeline/grid investment are essential to the 6-8% EPS growth target.
• Federal energy policy/IRA uncertainty: this is a reason CMS is exiting out-of-state non-utility renewables, reducing policy exposure over time.
• Severe weather and storm costs: more frequent storms create O&M/capex pressure and recovery risk in the near term.

• Q3 2026 earnings in late October 2026 - market will check full-year guidance and back-half execution.
• NorthStar Clean Energy asset sale of roughly $500M and progress toward the post-2027 pure-regulated model.
• Michigan Public Service Commission proceedings on storm-cost recovery and rate-base investments.
• A sustained decline in long-term interest rates, which would likely compress utility discount rates and support the multiple.

• High leverage: debt/equity is ~1.98x and LT debt has grown from $14.5B at end-2023 to $18.2B at Q2 2026.
• Persistent negative FCF: TTM FCF was -$1.91B, funded by debt/equity issuance; a prolonged capex cycle adds execution/financing risk.
• Weather/storm volatility and potential regulatory disallowances could dent the earnings growth path.
• Interest-rate spikes would pressure the multiple and could also raise refinancing costs.

At $68.35, CMS is a reasonable hold/accumulate for income investors, not a high-conviction buy. The regulated Michigan utility focus, 3.2% dividend, and 6-8% EPS growth algorithm are real positives, but they are offset by high leverage, negative FCF, and rate sensitivity. I would look for the $67.90 support to hold and for the NorthStar sale/Q3 report to confirm the story before expecting a move toward fair value.

Calculated by applying a 19.5x forward P/E to 2026 estimated EPS of $3.87 - a half-turn premium to the 5-year average P/E of 19.06, justified by the lower-risk pure-regulated pivot and 6-8% growth, but capped by the heavy leverage and negative FCF. This yields $75.50, below the $81.50 consensus target but above the current price.